Ibotenic Acid as a Neuroecological Stressor: Environmental Modulation of the Ibotenic Acid–Muscimol Ratio in Amanita muscaria and Its Toxicological Implications

Summary

The ratio of ibotenic acid to muscimol in Amanita muscaria mushrooms may be a dynamic marker influenced by environmental and post-harvest conditions, rather than a fixed species trait. Ibotenic acid has excitatory glutamatergic effects, while muscimol is a potent GABAergic compound, and ibotenic acid can convert to muscimol through decarboxylation. Abiotic stressors like temperature, drought, and soil chemistry, along with biotic factors such as microbial interactions and host-tree physiology, may affect the biosynthesis and transformation of these compounds. Post-harvest processes like drying, heating, and storage can further alter their ratio, potentially shifting neurotoxicological outcomes between excitatory and inhibitory effects. Direct controlled studies linking specific stressors to ibotenic acid biosynthesis remain limited.

Study at a glance

Abstract

Amanita muscaria is one of the most recognizable toxic mushrooms, yet its chemical and toxicological variability remains insufficiently understood. Its principal neuroactive isoxazole compounds, ibotenic acid and muscimol, differ substantially in pharmacological profile: ibotenic acid is associated mainly with glutamatergic excitatory activity, whereas muscimol is a potent GABAergic compound. Because ibotenic acid can be converted to muscimol through decarboxylation, the ibotenic acid–muscimol ratio may represent a dynamic marker of chemical phenotype rather than a fixed species-level trait. This review proposes a neuroecological model in which environmental and post-harvest stressors influence the biosynthesis, stability, and transformation of ibotenic acid and muscimol in A. muscaria. Abiotic factors such as temperature, drought, soil chemistry, nitrogen availability, and xenochemical exposure, as well as biotic factors including microbial interactions, host-tree physiology, developmental stage, and fungivory, may contribute to variation in fungal secondary metabolism. Post-harvest conditions such as drying, heating, cooking, extraction, and storage may further modify the ibotenic acid–muscimol ratio. This chemical variability may influence neurotoxicological outcome by shifting the balance between excitatory and inhibitory effects after human or animal exposure. The review integrates fungal stress biology, analytical toxicology, neuropharmacology, clinical toxicology, veterinary exposure, and public health concerns related to emerging A. muscaria products. Current evidence supports developmental variability, pro-cessing-related chemical transformation, and the need for standardized analytical quantification, but direct controlled studies linking specific environmental stressors to ibotenic acid biosynthesis remain limited. The proposed model identifies the ibotenic acid–muscimol ratio as a testable mechanistic marker connecting environmental stress in A. muscaria with variable neurotoxicological risk.